MarketPulse

JADE101

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Jade Biosciences Names Chief Medical Officer, Awards $12.7M Stock Option Grant

Clinical-stage biotech Jade Biosciences appoints Dr. Edward Conner as CMO, grants 500,000 stock options valued at $12.7M as inducement under Nasdaq rules.
JBIOautoimmune diseasesclinical-stage biotechnology
GlobeNewswire Inc.GlobeNewswire Inc.··Jade Biosciences, Inc.

Jade Biosciences Posts $127.4M Loss, Eyes 2028 Cash Runway With Pipeline Catalysts

Jade Biosciences reports $127.4M full-year loss, maintains $336.2M cash runway through mid-2028 with pipeline data catalysts starting Q2 2026.
JBIOmonoclonal antibodyclinical trials